PPARG and pulmonary fibrosis: Our study revealed that the deletion of USP25 can inhibit the STAT6/PPAR-γ signaling pathway by enhancing the ubiquitination of STAT6, thereby affecting macrophage M2 polarization, ultimately alleviating BLM-induced pulmonary fibrosis and bile duct ligation-induced liver fibrosis.